May 6, 2024
PHOENIX — Immunotherapy has revolutionized outcomes for patients with metastatic Merkel cell carcinoma (MCC). However, findings from a new study suggest that many patients who are […]
May 2, 2024
TOPLINE: Differences in prodromal or early symptoms of mpox between White non-Hispanic patients and patients of color suggest healthcare disparities in vulnerable populations. METHODOLOGY: There is […]
May 2, 2024
TOPLINE: The use of methotrexate (MTX) in patients with dermatomyositis (DM) did not increase their risk for interstitial lung disease (ILD) in a cohort study. METHODOLOGY: […]
April 30, 2024
BALTIMORE — Ice packs or topical anesthesia applied to the face before thermomechanical fractional injury therapy to treat wrinkles around the eyes provided satisfactory comfort to […]
April 30, 2024
On April 29, 2024, The US Food and Drug Administration (FDA) has accepted a Supplemental New Drug Application for tapinarof cream, 1%, for the topical treatment […]
April 29, 2024
TOPLINE: Most children and adolescents with chronic skin disorders may experience stigma, which is strongly associated with reduced quality of life (QOL) and childhood depression. METHODOLOGY: […]
April 26, 2024
TOPLINE: A large international cohort study identified a higher risk for cardiovascular diseases and mortality in patients with prurigo nodularis (PN), particularly among women and White […]
April 25, 2024
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the Biologics License Application (BLA) for prademagene zamikeracel (pz-cel), which is […]
April 24, 2024
In a small, nonrandomized controlled trial, the injectable calcitonin gene-related peptide (CGRP) inhibitor erenumab significantly reduced treatment-resistant flushing and erythema associated with rosacea. Skin-related quality-of-life (QOL) […]